Interestingly, BC possesses neuroprotective activity by modulating the Nrf2/Kelch-like ECH-associated protein 1 (KEAP1) pathway [46], where the expression of Nrf2 increases, while the expression of KEAP1, repressor of Nrf2, decreases [47]. Here, NFE2L2 is linked to breast cancer.